findmyKOL

Christopher Hoffmann, MD

Basic profile

Johns Hopkins University

ORCIDNPI
RegionBaltimore, MD · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2006–2026Why? →

Christopher Hoffmann is an Infectious Disease physician affiliated with Johns Hopkins University. OpenAlex indexes 231 publications with 5,452 citations (h-index 35); ClinicalTrials.gov lists 6 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
231publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,452citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
9NIH grants · 2006–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1830 E Monument St
Baltimore, MD 212052100

Telephone

410-502-2177

Registry record last updated 13 Oct 2009.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    38.9%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor15%
    Tivicay43%Dovato43%Isentress14%
    Part D<11 patients
    Protease Inhibitor5.6%
    Prezcobix100%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    35.9%
    Statin16.7%
    Atorvastatin Calcium83%Rosuvastatin Calcium17%
    Part D<11 patients
    ACE inhibitor4.6%
    Lisinopril56%Ramipril44%
    Part D<11 patients

    + 6 more classes in this area

  • Nervous system

    10.4%
    SSRI4.1%
    Escitalopram Oxalate50%Paroxetine Hcl50%
    Part D<11 patients
    Gabapentinoids4.1%
    Gabapentin100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)84.1% facility · 15.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

9 NIH research awards on record, funded 20062026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”